COVID Vaccination in Pregnancy Cuts Severe Disease Risk by 60%, Premature Birth by 30%

Unvaccinated pregnant people face dramatically increased risks of severe COVID disease, death, and premature births that carry significant health risks to newborns.
90 percent less likely to need intensive care
Vaccinated pregnant people showed dramatically lower rates of severe COVID outcomes compared to unvaccinated peers.

A large Canadian study has confirmed what mounting evidence has long suggested: vaccination against COVID during pregnancy meaningfully protects both mother and child, reducing severe illness by 60 percent and premature birth by 30 percent. The research, encompassing nearly 20,000 pregnant people and published in one of medicine's most respected journals, arrives at a moment of unusual tension — not because the science is uncertain, but because official guidance has moved in the opposite direction. In the long human story of medicine navigating politics, this chapter asks a familiar and uncomfortable question: when evidence and policy diverge, who bears the cost?

  • A study of nearly 20,000 pregnant people found vaccination cuts severe COVID risk by 60% and premature birth risk by 30% — one of the most definitive findings yet in this population.
  • Unvaccinated pregnant people face dramatically higher odds of hospitalization, intensive care, and death, while their newborns inherit the downstream risks of premature delivery.
  • The protective effect was strongest when vaccination occurred during pregnancy rather than before, upending any assumption that pre-conception vaccination is sufficient.
  • Even as this evidence lands in a top-tier medical journal, the CDC has quietly removed its recommendation that pregnant people receive COVID vaccination — a reversal celebrated by the Secretary of Health and Human Services.
  • Clinicians and researchers now face a fractured landscape where peer-reviewed science and federal public health guidance point in opposite directions, leaving pregnant individuals to navigate the gap.

A major Canadian study published in the Journal of the American Medical Association has found that COVID vaccination during pregnancy reduces the risk of severe disease by roughly 60 percent and premature birth by around 30 percent. Vaccinated pregnant people were 60 percent less likely to be hospitalized and a striking 90 percent less likely to require intensive care compared to unvaccinated peers. During the Delta and Omicron waves, vaccination was linked to a fifth and a third lower risk of preterm birth, respectively — reductions that carry real consequences for newborn health.

Perhaps most notably, the protective effect was even stronger when people were vaccinated during pregnancy rather than before conception. This distinction matters: it suggests that vaccination is not merely tolerated by the pregnant body but actively beneficial to it, a finding with direct implications for how clinicians counsel patients.

Pregnancy itself appears to heighten vulnerability to serious COVID outcomes, making the unvaccinated pregnant population a group facing compounded risk. The study's scale — nearly 20,000 participants — and its publication venue give its conclusions substantial scientific weight.

Yet the findings arrive against a dissonant backdrop. The CDC has recently removed its recommendation that pregnant people receive COVID vaccination, a decision the Secretary of Health and Human Services described with open approval. The result is a widening gap between what the evidence supports and what federal guidance now endorses — a gap that pregnant individuals, their doctors, and their communities will have to reckon with in the absence of clear official direction.

A study of nearly 20,000 pregnant people in Canada has found that vaccination against COVID during pregnancy cuts the risk of severe disease by roughly 60 percent and reduces the likelihood of premature birth by around 30 percent. The research, published in the Journal of the American Medical Association, represents one of the most comprehensive examinations to date of how the vaccine performs in this vulnerable population—and the findings are unambiguous.

Vaccinated pregnant people were about 60 percent less likely to require hospitalization for COVID compared to their unvaccinated counterparts. More strikingly, they were 90 percent less likely to need intensive care. During the Delta and Omicron waves specifically, vaccination was linked to a fifth lower risk of preterm birth during Delta and a third lower risk during Omicron. Premature birth carries substantial health consequences for newborns, making even modest reductions in risk medically significant.

The protective effect was even more pronounced when people received the vaccine while pregnant rather than before conception. This finding adds another layer to the evidence that vaccination during pregnancy is not merely safe but actively beneficial—a distinction that matters for public health messaging and individual decision-making.

Catching COVID while pregnant poses particular dangers. Unvaccinated pregnant people face dramatically elevated odds of severe illness and death. The virus does not treat pregnancy as a reason to spare its host; if anything, the physiological changes of pregnancy appear to increase vulnerability to serious outcomes.

Yet even as this evidence accumulates, the landscape of official guidance has shifted. The Trump administration's Centers for Disease Control and Prevention has removed its recommendation that pregnant people receive COVID vaccination. Robert F. Kennedy, Jr., the Secretary of Health and Human Services, stated he was "couldn't be more pleased" about the decision to drop the guidance. The timing creates a stark disconnect: a major peer-reviewed study confirming vaccine safety and efficacy in pregnancy arrives just as the federal agency responsible for public health recommendations has stepped back from endorsing vaccination in this population.

The Canadian study adds to what researchers describe as a growing body of evidence supporting vaccine safety across different demographic groups. The scale of the research—nearly 20,000 participants—and its publication in a top-tier medical journal give it substantial weight in the scientific literature. Yet the question of whether that evidence will influence clinical practice and individual choices remains open, particularly given the recent policy reversal.

Couldn't be more pleased about the decision to remove pregnancy vaccination recommendations
— Robert F. Kennedy, Jr., Secretary of Health and Human Services
A Conversa do Hearth Outra perspectiva sobre a história
Inventor

Why does pregnancy make COVID so much more dangerous in the first place?

Model

Pregnancy changes how the immune system works. The body has to tolerate a genetically foreign fetus, which means the immune response is naturally dampened. That same dampening that allows pregnancy to continue makes it harder to fight off infections like COVID.

Inventor

So the vaccine works by strengthening that weakened response?

Model

Partly. It trains the immune system to recognize the virus before exposure happens. And the antibodies the vaccine generates can cross the placenta, offering some protection to the baby too.

Inventor

The study found vaccination during pregnancy worked better than vaccination before pregnancy. Why would timing matter?

Model

If you're vaccinated before pregnancy, your immunity wanes over months. If you get vaccinated while pregnant, you have fresh antibodies circulating right when you're most vulnerable. You're also passing those fresh antibodies directly to the fetus.

Inventor

And the CDC just removed the recommendation for this?

Model

Yes. Despite the evidence. That's the tension the story sits in—the science is pointing one direction, policy another.

Inventor

What happens to pregnant people now?

Model

They have to decide for themselves, often without clear guidance from the agency they've been taught to trust. Some will get vaccinated anyway. Others won't. The study suggests that choice will matter.

Fale Conosco FAQ